Cargando…
Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2
Triple-negative breast cancer is a group of aggressive cancers with poor prognosis owing to chemoresistance, recurrence and metastasis. New strategies are required that could reduce chemoresistance and increases the effectiveness of chemotherapy. The results presented in this paper, showing that par...
Autores principales: | Carlisi, Daniela, De Blasio, Anna, Drago-Ferrante, Rosa, Di Fiore, Riccardo, Buttitta, Giuseppina, Morreale, Marco, Scerri, Christian, Vento, Renza, Tesoriere, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712634/ https://www.ncbi.nlm.nih.gov/pubmed/29354292 http://dx.doi.org/10.1038/cddiscovery.2017.78 |
Ejemplares similares
-
Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis
por: Carlisi, D, et al.
Publicado: (2016) -
Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer
por: D'Anneo, A, et al.
Publicado: (2013) -
MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells
por: Pratelli, Giovanni, et al.
Publicado: (2023) -
Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells
por: Lee, Kyu-Shik, et al.
Publicado: (2020) -
Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation
por: Drago-Ferrante, Rosa, et al.
Publicado: (2017)